Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injurySándor Bátkai, Pál Pacher, George Kunos et al.|The FASEB Journal|2007Cited by 240
Eosinophil Count and Serum Immunoglobulin E Levels in Atopic Dermatitis: Analysis of Upadacitinib Phase 2 Study FindingsLisa A. Beck, Emma Guttman‐Yassky, Jonathan I. Silverberg et al.|Journal of Allergy and Clinical Immunology|2019Cited by 7
817 Identification of Biomarkers and Mechanistic Insight for Upadacitinib in Crohn’s Disease: Serum Inflammatory Mediator Analysis From the Phase 2b CELEST StudyVermeire Séverine, Silvio Danese, Ana P. Lacerda et al.|The American Journal of Gastroenterology|2019Cited by 0